» Authors » Yu-Ping Zhou

Yu-Ping Zhou

Explore the profile of Yu-Ping Zhou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 282
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Liu C, Ma J, Ma J, Wang J, Li R, et al.
J Am Coll Cardiol . 2024 Sep; 84(12):1092-1103. PMID: 39260931
Background: B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide is the only blood biomarker in established risk calculators for pulmonary arterial hypertension (PAH). Profiling systemic-originated plasma immunoglobulin G (IgG) N-glycans,...
2.
Zhou Y, Liu C, Jing Z
JACC Asia . 2024 Aug; 4(8):590-593. PMID: 39156510
No abstract available.
3.
Dai Z, Deng K, Wang X, Yang D, Tang C, Zhou Y
World J Gastrointest Oncol . 2024 Jul; 16(6):2697-2715. PMID: 38994159
Background: Colorectal cancer (CRC) has a high incidence and mortality. Recent studies have shown that indole derivatives involved in gut microbiota metabolism can impact the tumorigenesis, progression, and metastasis of...
4.
Pan R, Zhou J, Wang X, Cen X, Zhou Y, Guo Y, et al.
Aging (Albany NY) . 2024 Jun; 16(11):10142-10164. PMID: 38870259
HCC, also known as hepatocellular carcinoma, is a frequently occurring form of cancer with an unfavorable prognosis. This research constructed a prognostic signature related to ubiquitination and investigated its correlation...
5.
Ren S, Feng J, Xiang T, Liao C, Zhou Y, Xuan R
World J Hepatol . 2024 May; 16(4):601-611. PMID: 38689740
Background: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver condition that typically arises in the middle and late stages of pregnancy. Short-chain fatty acids (SCFAs), prominent metabolites of the...
6.
Liu C, Zhou Y, Lian T, Li R, Ma J, Yang Y, et al.
Hypertension . 2023 Dec; 81(2):372-382. PMID: 38116660
Background: The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) is multifactorial and growing evidence has indicated that hematological disorders are involved. Clonal hematopoiesis of indeterminate potential (CHIP) has recently been...
7.
Xiang S, Deng K, Yang D, Yang P, Zhou Y
World J Hepatol . 2023 Dec; 15(11):1196-1209. PMID: 38075004
Chronic liver disease (CLD) imposes a heavy burden on millions of people worldwide. Despite substantial research on the pathogenesis of CLD disorders, no optimal treatment is currently available for some...
8.
He Y, Wang Y, Ma J, Li R, Wang J, Lian T, et al.
Vascul Pharmacol . 2023 Sep; 153:107216. PMID: 37699495
Pulmonary arterial hypertension (PAH) is a complex and progressive disease characterized by pulmonary arterial remodeling. Despite that current combination therapy has shown improvement in morbidity and mortality, a better deciphering...
9.
Lu D, Cheng C, Zhu X, Li J, Zhu Y, Zhou Y, et al.
Am J Cardiol . 2023 Aug; 204:207-214. PMID: 37556889
Because the 6-minute walking test (6MWT) is a self-paced submaximal test, the 6-minute walking distance (6MWD) is substantially influenced by individual effort level and physical condition, which is difficult to...
10.
Sun M, Zhu Y, Zhou Y, Zhu X, Yang Y, Cheng C, et al.
Catheter Cardiovasc Interv . 2023 Jul; 102(3):558-567. PMID: 37522190
Background: The efficacy and safety of percutaneous transluminal pulmonary angioplasty (PTPA) for Takayasu arteritis-associated pulmonary hypertension (TA-PH) remain unclear. Objectives: To examine the efficacy and safety of PTPA in TA-PH....